<DOC>
	<DOC>NCT01535196</DOC>
	<brief_summary>The investigators hypothesized that in vitamin D deficiency the 25-OH-D3 vitamin substitution improve the heart function in chronic heart failure. Type of study: Controlled, randomized, double blind, placebo control Number of patient: 300; 150 treated and 150 placebo controlled Type of drug: 180 000 IU 25-OH-D3 vitamin oil (Vigantol) per month in the 0,1,2,3,6, month Duration of study:1+1 year Primary end points: Survival rate, Ejection fraction by ultrasound, Brain natriuretic peptid, Secondary end points: Safety of D-vitamin supplementation, well being score, blood pressure, BMI Walking distant in 6 minutes Visits: Screening, Randomization, 1month, 2 month, 3 month, 6 month, 12 month, 24 month,</brief_summary>
	<brief_title>Vitamine D Treatment in Chronic Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>NYHA IIIV vitamin D level between 1030 ng/ml ejection fraction by ultrasound &lt; 40 % blood calcium &gt; 2,6 mmol/l urinary calcium &gt; 0,1 mmol/body weight kg/die blood phosphorus &gt; 1,45 mmol/l nephrolithiasis in the history GFR &lt; 30 ml/min vitamin D injection in the last 6 month actual 1,25OH2D3 vitamin treatment Myocardial infarction or serious coronaria stenosis in the anamnesis uncontrolled atrial fibrillation serious valve disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>vitamin D</keyword>
	<keyword>heart failure</keyword>
</DOC>